2011 saw the stem cell market earn revenues of $148.4 million in 2011 and this is forecast to reach $322 million by 2017. The segments covered include: bio-imaging and microscopy, cell biology tools, immunochemical, molecular biology tools, and protein biochemistry tools. <\/p>\n
The US is one of the major stem cell markets in the world, and the country has been witnessing a significant level of positive growth over the past few years. The US stem cell market was estimated to reach around $830 Million in 2010, up from $500 Million in 2009. <\/p>\n
This market growth can be attributed to a number of supporting factors, such as huge investment, strong demand, and rising disease incidences. Forecasters have predicted that these factors will lead to the US stem cell market generating revenues of $3 billion by 2013. <\/p>\n
A key step forward for the market has been the stem cell regulations in a few countries allowing the use of certain cell lines. In some countries such as France, for instance, stem cell regulations are being renewed for the procurement and use of stem cells. <\/p>\n
Standardised research guidelines are needed to control and encourage the development of gene therapy and stem cell treatments. Regenerative medicine is seen as an area with high future potential, as countries need ways to cope with the burden of an aging population. <\/p>\n
Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments. <\/p>\n
Organisations such as the International Society for Stem Cell Research (ISSCR) publish recommended guidelines on working with stem cells, but these are not binding. Governments must therefore come together to determine a standardised framework for innovative medical research, in order that positive results and long-term follow-up data can be produced to solidify the reputation and investment potential of the regenerative medicine market. <\/p>\n
For more information on the stem cell market, see the latest research: Stem Cell Market Report <\/p>\n
Follow us on Twitter @CandMResearch <\/p>\n
About: Companiesandmarkets.com is a UK based organisation, home to one of the worlds largest databases of market research reports and company profiles from leading global publishers and industry analysts. Multinational brands across major industries rely daily on companiesandmarkets.com for strategic market research and incisive company profiles. Call +44 (0)203 086 8600. <\/p>\n<\/p>\n
Read more here: <\/p>\n
Stem cell market to reach $322 million by 2017<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" 2011 saw the stem cell market earn revenues of $148.4 million in 2011 and this is forecast to reach $322 million by 2017. Continue reading